NAD+ Near Me: 500 mg of Material Costs $26.00 in a Vial

Six kinds of business turn up for this query. Unlike the equivalent search for a research peptide, most of them really do offer the thing named on the sign.

Only the last row is a category error, and it is a common one. NMN and NR are precursors sold as supplements; they are different substances with their own separate regulatory histories, not checked for this page and not asserted here. A capsule off a shelf is not the thing an infusion menu is offering.

Everything above the last row is a genuine service. The question worth asking is not whether it is real but what is in it, and that question has a documented reason for existing.

Clinics price sessions, not milligrams. Sessions are often stepped by the amount infused, discounted inside packages, and sometimes wrapped into a membership. There is no national rate to look up and no formulary position, because no NAD+ drug product is approved, so nothing in the FDA approved drug database exists to price against.

We are not going to print a price range for local clinics. The ranges circulating online come from unsourced aggregation rather than from any published schedule, and quoting them would give you a number with nothing behind it. What can be priced honestly is the material.

Take the figure a clinic quotes you, ask how many milligrams are going in, find the matching row, and subtract. The remainder is the facility and the service, and it is worth what it is worth. If you want the multiple rather than the difference, divide the session price by the milligrams infused and multiply by 100, then compare the result against $5.20.

The reason the arithmetic is worth doing at all is that the session price is often taken as a proxy for how much material is involved, and it is not one. A clinic charging twice as much as the one down the road is not necessarily infusing twice as much of anything.

These are short, answerable, and a clinic that handles them well has told you more than any review page will.

One: is the NAD+ pharmaceutical grade or food grade? This is the specific failure FDA named. Its compounding notice, content current as of 30 October 2024, states that the agency "is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products", and that ingredients "identified as food grade are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins, which can harm patients".

Two: which pharmacy or outsourcing facility compounds it? A sterile preparation comes from a 503A pharmacy or a registered 503B outsourcing facility, and FDA publishes a list of registered outsourcing facilities you can check a name against. A clinic that cannot name its source has told you something.

Three: does the batch certificate report endotoxin testing? Not identity, not purity, endotoxin. The same FDA notice reports adverse event reports after use of NAD+ injectable drugs including "severe chills, shaking, vomiting and fatigue with some requiring medical treatment", reactions it describes as consistent with excessive endotoxin levels. That is the failure mode a certificate reporting only HPLC and mass spec results will pass straight through. FDA's compounding rules state that bulk drug substances must be accompanied by a valid certificate of analysis and come from an establishment registered under section 510 of the FD&C Act.

One further piece of context that clinics rarely volunteer, and which runs in NAD's favour: on FDA's 503A category lists updated 14 May 2026, Nicotinamide Adenine Dinucleotide (NAD) sits in category 1, bulk drug substances under evaluation, meaning FDA does not intend to act against a compounder using it provided its guidance conditions are met. That is non-enforcement during an evaluation, not approval, and our regulatory page works through what it does and does not cover.

People searching this query in different places get noticeably different results, and the reason is that the clinic side of NAD+ is regulated where you are rather than federally.

Who may place an intravenous line, under whose supervision, on whose order, and what a facility must be licensed as are questions for state medical practice acts, nursing boards and pharmacy boards. Those answers genuinely differ. A model that supports a walk-in drip bar in one state may require a different arrangement in another, which is why the density of NAD+ services on a map varies in a way that has nothing to do with demand.

Two things do not vary. The federal compounding position on the bulk substance is the same everywhere, and a mail-order research vial is the same transaction in every state. That asymmetry is most of why the local answer feels inconsistent and the mail-order one does not.

The alternative to a local session is a parcel, and the honest description of the trade is that you take on everything the clinic was doing.

What arrives is 1,000 mg of dry coenzyme labelled for laboratory research use, with a batch code and no concentration at all until a diluent is added. Made up to 10 mL it is 100 mg/mL, so one unit on a U-100 barrel is 0.01 mL and holds 1 mg, 10 units draws 10 mg, and a full 100 unit barrel holds 100 mg. That last sentence is never true of a peptide vial on this site, where 10 units on a 10 mg vial draws 500 mcg. The scale is different by a factor of twenty and it is the single easiest thing to get wrong.

The cost side is fixed and public: $104.00 at list, $52.00 with the code PEPTIDEDECK, which is $10.40 and $5.20 per 100 mg. Quantity tiers of three, five and ten take 3%, 5% and 10% off list, giving $10.09, $9.88 and $9.36 per 100 mg, all above the single vial code rate. Free carriage starts at $250, which five vials at $52.00 reach. The price page runs the landed arithmetic and the coupon page covers the code.

What is not fixed is anything to do with preparation, and this page does not cover it. Amounts belong on our NAD reference page, which works its own figures from a 500 mg vial at 3 mL, or 166.7 mg/mL. The NAD calculator will run any volume you enter, and the storage guide covers handling. These are laboratory figures for research material.

Worth stating plainly, because this is the one compound in the series where the local option is not a mirage.

A clinic supplies three real things: a sterile preparation somebody else is accountable for, a trained person administering it, and a room to sit in if something goes wrong. Those have value, and the FDA adverse event reports quoted above are precisely the scenario in which the third one matters.

What proximity does not supply is a better molecule. The bulk substance behind a clinic bag and behind a research vial moves through the same wholesale market, which is exactly the point of FDA's notice about repackagers. A local address changes who you can hold accountable, not what was in the drum. That is why the three questions above are the ones worth asking, and why a clinic that answers them precisely is worth more than a cheaper one that answers with a treatment plan.

If you go the other way, the sourcing criteria are the same set of checks applied to a listing instead of a clinic, and our supplier checklist lays them out in order.